Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial of Methylergonovine Prophylaxis After Dilation and Evacuation Abortion

NCT02408965 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02408965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02408965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial of Methylergonovine Prophylaxis After Dilation and Evacuation Abortion
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2015
Completion date
March 31, 2017
Enrollment
284 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhage